Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT04939272 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04939272
- Sponsor
- City of Hope Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-29
- Primary completion
- 2027-02-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.